Skip to content
GLP-1 Savers
Menu
Ranked #291 · Watch List

The Edit review

Compounded semaglutide at $259 a month and tirzepatide at $349, published openly and then overprinted with a first-month promotion that carries no end date — on a site whose own policies say a document behind the account gate overrides them.

By Grant Ashford, Founder & Pricing Editor

Est. first month

From $259/mo

Save ~81% vs brand-name

$259/mo month-to-month ($200 for the first month, on a promotion with no published end date)

Get this deal Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Value Score.
Pricing to watch. The standing rates are $259 and $349 and they are published plainly, which is more than most of this batch manages. What sits on top is a first-month promotion printed larger than the rate it discounts: $200 and $300, struck through from $259 and $349, labeled limited time with no end date, no code and no statement of whether it applies to the longer plans. The three- and six-month figures are single charges rather than monthly rates — $575, $1,065, $855 and $1,575, billed once at the start — and the per-month numbers beside them are arithmetic, not a billing cadence. The published cancellation and refund policies also say they do not govern: a membership agreement behind the account gate controls where the two differ.

How much does The Edit cost?

The price The Edit publishes is $259/mo month-to-month ($200 for the first month, on a promotion with no published end date). Tirzepatide is listed at $349/mo month-to-month ($300 for the first month). We flag this one to watch: confirm the ongoing rate with The Edit before you count on it, because a low first month can step up afterward. That works out about 81% under our ~$1,349/mo brand-name cash reference.

Semaglutide
$259/mo month-to-month ($200 for the first month, on a promotion with no published end date)
Tirzepatide
$349/mo month-to-month ($300 for the first month)
Coverage
All 50 states claimed, no list published
Brand-name
Compounded only

The Value Score card

The Edit scored on our six published factors. See the methodology.

Lowest Real Price54/100
No Teaser-Rate Bait54/100
Both Molecules92/100
Nationwide Availability72/100
Easy Cancellation82/100
Reputation91/100

Why it's a deal

  • The standing month-to-month rates are published plainly before any intake, at $259 and $349, rather than being reachable only through a signup
  • The prepay options are stated as single charges with real totals — $575 and $1,065 on semaglutide, $855 and $1,575 on tirzepatide — and the site says outright that they are billed once at the start of the plan
  • Getting started is free with no card on file, which is stated as a fact rather than implied by omission
  • The dispensing pharmacy is named with a street address and a phone number, and the medical practice is named with a medical director whose identifier can be checked against a federal registry
  • The shipping policy corrects the site's own marketing rather than repeating it: it states an average of four to twelve business days from prescription and says the two-day references elsewhere describe transit only
  • A hormone line is priced on the same open basis, so the GLP-1 figures sit in a visible context

Read the fine print

  • The first-month promotion is printed larger than the rate it discounts, struck through from the standing price, labeled limited time with no end date, no code, and no statement of whether it applies to the prepay plans at all
  • The three- and six-month figures are single charges, not monthly rates; the per-month numbers printed beside them are arithmetic a buyer performs, not a cadence anyone is billed on
  • The published cancellation and refund policies say they do not govern. Where they differ from a membership agreement held behind the account gate, that agreement controls — and nothing on the public site constitutes it
  • All fifty states is claimed and hedged in the same paragraph, and no list is published anywhere across the site
  • The named pharmacy is described as one member of a plural pharmacy network whose other members are not named, and no 503A or 503B designation appears anywhere
  • No consultation fee is priced for a weight-loss patient, while the cancellation policy contemplates one in the abstract and says visit fees are not refundable once the visit has occurred
  • Support is email only with no published hours and no phone line, for a brand shipping temperature-sensitive medication

The bottom line

Best for: Shoppers who want a named pharmacy and a named medical director behind the prescription, and who will budget from month two rather than month one. Compounded semaglutide at $259 a month and tirzepatide at $349, published openly and then overprinted with a first-month promotion that carries no end date — on a site whose own policies say a document behind the account gate overrides them.

Ranked #291 of 418 programs we track — see our #1 deal, CoreAge Rx, for comparison.

Get this deal

Compare with other deals

The programs scoring closest to The Edit, out of 417 others we track.

Shopping The Edit against a specific rival? We put it head to head with our top-scoring pick on CoreAge Rx vs The Edit, and every program that undercuts or outscores it — starting with Silhouette MD, the closest match on score — is ranked on the The Edit alternatives ranking.

More programs we track (24)

387 more are reviewed too — see every GLP-1 program we track, ranked.

Pricing and coverage on this page were read from The Edit's own website on ; the Value Score is our editorial judgment per the methodology. “% vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on The Edit's site. Not medical advice; see our disclosure.

See every program ranked by price →

← Back to all deals